IPS Pharma · Indica-dominant· New release

IPS Pharma T22 RS11

Bred by IPS Pharma.

THC20–24% THCCultivationIndoor
IPS Pharma T22 RS11 — botanical reference image
Educational reference. Not medical advice. Medical cannabis is a prescription-only medicine in the UK — consult a specialist clinician.

History & Producer

Origin

Rainbow Sherbet 11 phenotype.

Genetics

Lineage

Pink Guava × OZK

Indica 65%Sativa 35%

Cannabinoid & Production Profile

Specifications

THC
20–24% THC
CBD
<1.0%
Classification
Indica-dominant
Cultivation
Indoor
Irradiation
Beta (e-beam)

Dominant Terpenes

Aromatic Compounds

  • Myrcene0.85%
  • β-Caryophyllene0.42%
  • Linalool0.21%

Sensory Profile

Appearance, Flavour & Aroma

Appearance

Vivid purple buds with neon pistils.

Flavour

Tropical fruit, candy, gas.

Aroma

Tropical, sweet gas.

Reported Effects

Effect Profile

Aggregated from patient diaries and prescriber feedback. Intensity is relative within this strain's profile, not an absolute clinical measure.

Relaxed88%
Sleepy82%
Body Heaviness76%
Pain Relief78%
Euphoric58%
Appetite60%

Condition Recommendations

Discussed Indications

  • Chronic pain

    Evidence · Emerging

    Myrcene-dominant profile commonly prescribed for nocturnal musculoskeletal and neuropathic pain.

    Strong fit
  • Insomnia / sleep maintenance

    Evidence · Emerging

    Sedating terpene profile typically prescribed as an evening cultivar.

    Strong fit
  • Treatment-resistant anxiety

    Evidence · Limited

    Calming profile may help; high THC unsuitable for THC-naive patients.

    Moderate fit
  • Daytime productivity

    Evidence · Anecdotal

    Sedating profile is generally unsuitable for daytime cognitive demands or driving.

    Caution

Not a substitute for a prescriber's assessment. Suitability depends on tolerance, comorbidities and concomitant medication.